yet, but filip ude has bought bonmarche, and several other retailers that had been on the rocks, jaegerll happen to theirjobs. looking father —— further afield, the pharmacy giant boots has cut its earnings forecast because it is struggling with generic alternatives to branded drugs. it owns the boots chain in the uk as well as an equivalent business called walgreens in the us. michelle fleury is watching this in the us stock exchange. what more can you tell us about walgreens? we have heard from donald trump in the past, talking about trying to lower drug prices and putting pressure on the industry as a result of that, as you are starting to see margins being squeezed, and that has had a knock—on effect on walgreens. the other thing, the company talks about wea kness other thing, the company talks about weakness in the uk market. no doubt some of that relates to brexit, so taken altogether, it has been a much more disappointing quarter for the company and the worst since walgreens merged with boots. you would think that a business selling medicines might be immune to retail pressures ,